Prophylactic Minimally Invasive Surfactant Evaluation

Recruiting now · Phase 4

Conditions studied: Respiratory Distress Syndrome, Newborn, Premature Birth

In brief

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

Key facts

Study ID

NCT06007547

Run by

Endeavor Health

People needed

200

Starts

2024-01-01

Expected to finish

2027-07-31

Last updated by the study team

2025-08-07

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Gestational age <30 weeks
• Antenatal consent from Parent

You may not qualify if…

• Congenital anomalies
• Alternate cause of respiratory distress

Where it is running

• Northshore University Healthsystem — Evanston, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.